Prevalence of genes of OXA-23 carbapenemase and AdeABC efflux pump associated with multidrug resistance of Acinetobacter baumannii isolates in the ICU of a comprehensive hospital of Northwestern China

International Journal of Environmental Research and Public Health

Volumn 12, Issue 8, 2015, Pages 10079-10092

  Jia, Wei ^a,b   Li, Caiyun ^a,b   Zhang, Haiyun ^b,c   Li, Gang ^a,b   Liu, Xiaoming ^a   Wei, Jun ^a,b  

^a Ningxia Key Laboratory of Reproduction and Genetics   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c First People's Hospital of Mudanjiang City   (China)

Author keywords

Acinetobacter baumannii; Efflux pump; Multidrug resistance; Nosocomial infections; Oxacillinase

Indexed keywords

CEFOTAXIME; IMIPENEM; MOXIFLOXACIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; CARBAPENEMASE;

BACTERIUM; CYTOPLASM; DRUG RESISTANCE; EPIDEMIOLOGY; GENE; MOLECULAR ANALYSIS; PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADEABC GENE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHINA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; OXA23 GENE; PREVALENCE; VERY ELDERLY; ACINETOBACTER INFECTIONS; DRUG EFFECTS; GENE; GENETICS; METABOLISM; MICROBIOLOGY;

CHINA;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, MDR; INTENSIVE CARE UNITS; PREVALENCE;

EID: 84981332688     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph120810079     Document Type: Article

References (44)

1. Peleg, A.Y.; Seifert, H.; Paterson, D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21, 538–582.
2. Dai, X.T.; Sun, F.J.; Chen, Z.H.; Luo, G.M.; Feng, W.; Xiong, W.; Xia, P.Y. The epidemiology and resistance mechanisms of Acinetobacter baumannii isolates from the respiratory department ICU of a hospital in China. Microb. Drug Resist. 2014, 20, 618–622.
3. OXA-23 and armA in multidrug-resistant Acinetobacter baumannii isolated from a hospital in South Korea. J. Med. Microbiol. 2013, 62, 836–844.
4. OXA-182-carrying Acinetobacter nosocomialis in Korea. Diagn. Microbiol. Infect. Dis. 2013, 77, 160–163.
5. Sung, J.Y.; Koo, S.H.; Cho, H.H.; Kwon, K.C. Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea. Ann Lab Med. 2013, 33, 279–282.
6. Lean, S.S.; Suhaili, Z.; Ismail, S.; Rahman, N.I.; Othman, N.; Abdullah, F.H.; Jusoh, Z.; Yeo, C.C.; Thong, K.L. Prevalence and genetic characterization of carbapenem- and polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in Terengganu, Malaysia. ISRN Microbiol. 2014, doi:10.1155/2014/953417.
7. Hasan, B.; Perveen, K.; Olsen, B.; Zahra, R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J. Med. Microbiol. 2014, 63, 50–55.
8. Peymani, A.; Higgins, P.G.; Nahaei, M.R.; Farajnia, S.; Seifert, H. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Int. J. Antimicrob. Agents 2012, 39, 526–528.
9. Aly, M.; Tayeb, H.T.; Al Johani, S.M.; Alyamani, E.J.; Aldughaishem, F.; Alabdulkarim, I.; Balkhy, H.H. Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Euro. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1223–1228.
10. OXA-23 from hospitals in central Taiwan. J. Microbiol. Immunol. Infect. 2013, 46, 419–424.
11. Apisarnthanarak, A.; Pinitchai, U.; Warachan, B.; Warren, D.K.; Khawcharoenporn, T.; Hayden, M.K. Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: An analysis before and after extensive flooding. Am. J. Infect. Control 2014, 42, 116–121.
12. Xiao, Y.; Wei, Z.; Shen, P.; Ji, J.; Sun, Z.; Yu, H.; Zhang, T.; Ji, P.; Ni, Y.; Hu, Z.; et al. Bacterial-resistance among outpatients of county hospitals in China: Significant geographic distinctions and minor differences between central cities. Microbes Infect. 2015, doi:10.1016/j.micinf.2015.02.001.
13. Perez, F.; Hujer, A.M.; Hujer, K.M.; Decker, B.K.; Rather, P.N.; Bonomo, R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51, 3471–3484.
14. Li, X.Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria: An update. Drugs 2009, 69, 1555–1623.
15. Rumbo, C.; Gato, E.; Lopez, M.; Ruiz de Alegria, C.; Fernandez-Cuenca, F.; Martinez-Martinez, L.; Vila, J.; Pachon, J.; Cisneros, J.M.; Rodriguez-Bano, J.; et al. Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.2013, 57, 5247–5257.
16. Siroy, A.; Cosette, P.; Seyer, D.; Lemaitre-Guillier, C.; Vallenet, D.; Van Dorsselaer, A.; Boyer-Mariotte, S.; Jouenne, T.; De, E. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J. Proteome Res.2006, 5, 3385–3398.
17. Toledo, P.V.M.; Arend, L.N.; Pilonetto, M.; Costa Oliveira, J.C.; Luhm, K.R. Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: An urban perspective in South Brazil. J. Hosp. Infect. 2012, 80, 351–353.
18. Dolejska, M.; Villa, L.; Poirel, L.; Nordmann, P.; Carattoli, A. Complete sequencing of an IncHI1 plasmid encoding the carbapenemase NDM-1, the ArmA 16s RNA methylase and a resistance-nodulation-cell division/multidrug efflux pump. J. Antimicrob. Chemother. 2013, 68, 34–39.
19. Hu, W.S.; Yao, S.M.; Fung, C.P.; Hsieh, Y.P.; Liu, C.P.; Lin, J.F. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51, 3844–3852.
20. Koh, T.H.; Sng, L.H.; Wang, G.C.; Hsu, L.Y.; Zhao, Y. Carbapenemase and efflux pump genes in Acinetobacter calcoaceticus—Acinetobacter baumannii complex strains from Singapore. J. Antimicrob. Chemother. 2007, 60, 1173-1174.
21. KPC-2) and efflux pump (AcrAB) on β-lactam susceptibility in KPC-producing Enterobacteriaceae. FEMS Microbiol. Lett. 2013, 348, 120–126.
22. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard-9th Edition. Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2012.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2014.
24. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281.
25. Shi, W.F.; Jiang, J.P.; Xu, N.; Huang, Z.M.; Wang, Y.Y. Inhibitory effects of reserpine and carbonyl cyanide m-chloro-phenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii. Chin. Med. J. 2005, 118, 340–343.
26. Jia, W.; Li, G.; Wang, W. Prevalence and antimicrobial resistance of Enterococcus species: A hospital-based study in China. Int. J. Environ. Res. Public Health 2014, 11, 3424–3442.
27. Hu, H.; Manos, J. Pulsed-field gel electrophoresis of Pseudomonas aeruginosa. Methods Mol. Biol. 2015, 1301, 157–170.
28. Seifert, H.; Dolzani, L.; Bressan, R.; van der Reijden, T.; van Strijen, B.; Stefanik, D.; Heersma, H.; Dijkshoorn, L. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 2005, 43, 4328–4335.
29. Walsh, T.R. Emerging carbapenemases: A global perspective. Int. J. Antimicrob. Agents 2010, 36, S8–S14.
30. OXA-23 in Acinetobacter spp. in China: Main roles of conjugative plasmid pAZJ221 and transposon TN2009. Antimicrob. Agents Chemother. 2015, 59, 1998–2005.
31. Mendes, R.E.; Bell, J.M.; Turnidge, J.D.; Castanheira, M.; Jones, R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 2009, 63, 55–59.
32. OXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob. Agents Chemother. 2010, 54, 4575–4581.
33. Wang, J.; Ruan, Z.; Feng, Y.; Fu, Y.; Jiang, Y.; Wang, H.; Yu, Y. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PloS ONE 2014, 9, e104882.
34. Abbott, I.; Cerqueira, G.M.; Bhuiyan, S.; Peleg, A.Y. Carbapenem resistance in Acinetobacter baumannii: Laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev. Anti Infect. Ther. 2013, 11, 395–409.
35. Novovic, K.; Mihajlovic, S.; Vasiljevic, Z.; Filipic, B.; Begovic, J.; Jovcic, B. Carbapenem-resistant Acinetobacter baumannii from Serbia: Revision of CarO classification. PloS ONE 2015, 10, e0122793.
36. Zhao, S.Y.; Jiang, D.Y.; Xu, P.C.; Zhang, Y.K.; Shi, H.F.; Cao, H.L.; Wu, Q. An investigation of drug-resistant Acinetobacter baumannii infections in a comprehensive hospital of East China. Ann. Clin. Microbiol. Antimicrob. 2015, doi:10.1186/s12941-015-0066-4.
37. Higgins, P.G.; Poirel, L.; Lehmann, M.; Nordmann, P.; Seifert, H. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2009, 53, 5035–5038.
38. Coelho, J.M.; Turton, J.F.; Kaufmann, M.E.; Glover, J.; Woodford, N.; Warner, M.; Palepou, M.F.; Pike, R.; Pitt, T.L.; Patel, B.C.; et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J. Clin. Microbiol. 2006, 44, 3623–3627.
39. Yoon, E.J.; Courvalin, P.; Grillot-Courvalin, C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: Major role for adeabc overexpression and adeRS mutations. Antimicrob. Agents Chemother. 2013, 57, 2989–2995.
40. Hou, P.F.; Chen, X.Y.; Yan, G.F.; Wang, Y.P.; Ying, C.M. Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii. Chemotherapy 2012, 58, 152–158.
41. OXA-66 gene. Ann. Clin. Lab. Sci. 2010, 40, 43–48.
42. Ruzin, A.; Keeney, D.; Bradford, P.A. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus—Acinetobacter baumannii complex. J. Antimicrob. Chemother.2007, 59, 1001–1004.
43. Coyne, S.; Courvalin, P.; Perichon, B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 2011, 55, 947–953.
44. Yoon, E.J.; Nait Chabane, Y.; Goussard, S.; Snesrud, E.; Courvalin, P.; De, E.; Grillot-Courvalin, C. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. mBio 2015, doi:10.1128/mBio.00309-15.